首页> 外国专利> IMMUNOFLUORESCENCE KIT FOR DETECTING PD-L1 EXPRESSION OF PERIPHERAL BLOOD CIRCULATING TUMOR CELLS OF KIDNEY CANCER PATIENT AND DETECTION METHOD

IMMUNOFLUORESCENCE KIT FOR DETECTING PD-L1 EXPRESSION OF PERIPHERAL BLOOD CIRCULATING TUMOR CELLS OF KIDNEY CANCER PATIENT AND DETECTION METHOD

机译:用于检测肾癌患者外周血循环肿瘤细胞的PD-L1表达的免疫荧光试剂盒

摘要

An immunofluorescence kit for detecting a PD-L1 expression of peripheral blood circulating tumor cells of a kidney cancer patient and a detection method. The kit comprises 45 mL of diluent, 1 mL of destaining solution, 0.5 mL of staining solution A, 1 mL of staining solution B, 200 μl of methanol, 200 μl of 2% PFA, 100 μl of 10% goat serum, 100 μl of primary antibody suspension composed of mouse anti-CK, rat anti-CD45 and rabbit anti-PD-L1, 100 μl of secondary antibody suspension composed of a fluorescently labeled goat anti-mouse, a fluorescently labeled goat anti-rat and a fluorescently labeled goat anti-rabbit, and a DAPI mounting medium. According to the detection method, the PD-L1 expression condition of a patient with advanced or recurrent kidney cancer can be detected without acquiring a tissue specimen by means of needle biopsy.
机译:一种用于检测肾癌患者外周血循环肿瘤细胞PD-L1表达的免疫荧光试剂盒及检测方法。 该试剂盒包含45ml稀释剂,1ml剥离溶液,0.5ml染色溶液A,1ml染色溶液B,200μl甲醇,200μl2%PFA,100μl10%山羊血清,100μl 由小鼠抗CK,大鼠抗CP45和兔抗PD-L1,100μL二次抗体悬浮液组成的初级抗体悬浮液组成,由荧光标记的山羊抗小鼠组成,荧光标记的山羊抗大鼠和荧光标记的荧光标记 山羊抗兔和DAPI安装介质。 根据检测方法,可以通过通过针活检显示具有晚期或复发性肾癌的患者的患者的PD-L1表达状况。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号